08.24.2022
Prevention
$2,080,024.00
31 months
Combination therapy with BIOlogics and Partial enteral nutrition In adults with active ileocolonic Crohn's disease: The BIOPIC Study
This study will compare clinical remission/response rates to standard treatment with adalimumab between a group of CD patients on an unrestricted diet and another in which half of their habitual diet is replaced by enteral nutrition.